# Different β -Blockers in STEMI and Primary PCI

> **NCT04221919** · NA · UNKNOWN · sponsor: **Qilu Hospital of Shandong University** · enrollment: 1200 (estimated)

## Conditions studied

- Primary PCI

## Interventions

- **DRUG:** β -Blockers

## Key facts

- **NCT ID:** NCT04221919
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01
- **Primary completion:** 2021-01
- **Final completion:** 2025-01
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2020-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04221919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04221919, "Different β -Blockers in STEMI and Primary PCI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04221919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*